Breaking News
FONT-SIZE Plus   Neg
Share SHARE

Brenntag Lifts Dividend After Annual Profit Climbs 21% - Update

Chemical distributor Brenntag AG (BNTGF.PK) Thursday reported more than 21 percent increase in annual profit, supported by revenue growth across all regions. The firm announced a 20 percent increase in dividend.

Profit attributable to Brenntag's shareholders increased 21.2 percent to 336.2 million euros ($434.9 million) from 277.4 million euros. Pre-tax profit climbed 14.1 percent to 478.8 million euros.

Sales increased 11.6 percent to 9.69 billion euros from 8.68 billion euros in the prior year. The growth was 7.7 percent on a forex adjusted basis.

Sales grew nearly 6 percent in Europe to 4.549 billion euros. According to the company, business in Europe proved to be resilient despite the challenging macroeconomic situation. The Multisol Group, which was acquired in the previous year, made a solid contribution to Brenntag's results.

North America sales increased 12.5 percent to 3.065 billion euros, in spite of a more difficult market environment. During the year, the firm made two acquisitions in the region - that of the TER Corp. and the Altivia Corp.

Sales in Latin America totaled 919 million euros, up nearly 14 percent from the prior year. At the end of the year, Brenntag acquired the Delanta Group, a distributor of specialty chemicals. This purchase will strengthen its business in the southern part of Latin America in particular.

Asia Pacific sales surged 70.3 percent to 707.6 million euros. The Zhong Yung Group in China, acquired in 2011, significantly contributed to the results thanks to its strong performance in the second half of the year.

The firm announced a dividend of 2.40 euros per share, up 20 percent from last year, reflecting the results.

Steven Holland, CEO, said, "Although the global economic situation provided more and more challenges in the past year, we succeeded in improving our results once again...We are also benefiting from our special combination of local presence and global strength."

Brenntag believes it is extremely well positioned to overcome the challenging market conditions once again in 2013.

The stock slid 0.2 percent on Wednesday to close at 113.85 euros.

Register
To receive FREE breaking news email alerts for Brenntag AG and others in your portfolio

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Editors Pick
Swiss drug maker Roche Holding said a late-stage trial of its breast cancer drug Kadcyla did not provide superior results compared with an existing therapy. FCA US, until recently known as Chrysler, said Friday it is recalling 257,000 Dodge Ram pickups. The auto maker says the rear axle pinion nut on certain model year 2005 Dodge Ram 1500 trucks may loosen due to an undersized spline on the pinion gear. If the pinion nut loosens, the rear axle may... This medical device company has a very impressive track record of growing business over the past decade. increasing sales from $490.2 million in 2004 to $1.72 billion this year. The Silicone Hydrogel daily disposable lens portfolio constitutes a major avenue for growth.
comments powered by Disqus
FREE Newsletters, Analysis & Alerts

 

Stay informed with our FREE daily Newsletters and real-time breaking News Alerts. Sign up to receive the latest information on business news, health, technology, biotech, market analysis, currency trading and more.